N@N

Stephen Baxter Maintained (THC) at Buy with Decreased Target to $71 on, Oct 20th, 2023

Stephen Baxter of Wells Fargo, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Decreased Target from $83 to $71 on, Oct 20th, 2023.

Stephen has made no other calls on THC in the last 4 months.

There are 10 other peers that have a rating on THC. Out of the 10 peers that are also analyzing THC, 1 agrees with Stephen's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $89 on, Tuesday, August 1st, 2023

These are the ratings of the 9 analyists that currently disagree with Stephen

---

• Sarah James of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $94 on, Thursday, September 14th, 2023
• Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $98 on, Monday, August 14th, 2023
• A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Wednesday, August 2nd, 2023
• John Ransom of "Raymond James" Maintained at Strong Buy with Increased Target to $95 on, Wednesday, August 2nd, 2023
• Andrew Mok of "UBS" Maintained at Strong Buy with Increased Target to $104 on, Tuesday, August 1st, 2023
• Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, August 1st, 2023
• Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $87 on, Tuesday, August 1st, 2023
• Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $94 on, Tuesday, July 11th, 2023
• Ryan MacDonald of "Truist Securities" Maintained at Strong Buy with Increased Target to $92 on, Tuesday, June 20th, 2023

Contributing Sources

---